ID   POLN_HEVCH              Reviewed;        1693 AA.
AC   Q81862; Q81344; Q81863; Q81864; Q81865; Q81866; Q81867; Q81868; Q81869;
DT   30-NOV-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 104.
DE   RecName: Full=Non-structural polyprotein pORF1;
DE   Includes:
DE     RecName: Full=Methyltransferase;
DE              EC=2.1.1.-;
DE   Includes:
DE     RecName: Full=Papain-like cysteine protease;
DE              Short=PLP;
DE              EC=3.4.22.-;
DE   Includes:
DE     RecName: Full=NTPase/helicase;
DE              EC=3.6.4.-;
DE   Includes:
DE     RecName: Full=RNA-directed RNA polymerase;
DE              Short=RdRp;
DE              EC=2.7.7.48;
GN   ORFNames=ORF1;
OS   Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) (HEV).
OC   Viruses; Riboviria; Orthornavirae; Kitrinoviricota; Alsuviricetes;
OC   Hepelivirales; Hepeviridae; Orthohepevirus; Orthohepevirus A.
OX   NCBI_TaxID=652674;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=8346669; DOI=10.1016/0168-1702(93)90024-h;
RA   Bi S.L., Purdy M.A., McCaustland K.A., Margolis H.S., Bradley D.W.;
RT   "The sequence of hepatitis E virus isolated directly from a single source
RT   during an outbreak in China.";
RL   Virus Res. 28:233-247(1993).
RN   [2]
RP   FUNCTION (NTPASE/HELICASE).
RX   PubMed=20592074; DOI=10.1128/jvi.00492-10;
RA   Karpe Y.A., Lole K.S.;
RT   "RNA 5'-triphosphatase activity of the hepatitis E virus helicase domain.";
RL   J. Virol. 84:9637-9641(2010).
RN   [3]
RP   FUNCTION (NTPASE/HELICASE), AND MUTAGENESIS OF LEU-1110 AND VAL-1120.
RX   PubMed=24630891; DOI=10.1016/j.virusres.2014.02.018;
RA   Devhare P., Sharma K., Mhaindarkar V., Arankalle V., Lole K.;
RT   "Analysis of helicase domain mutations in the hepatitis E virus derived
RT   from patients with fulminant hepatic failure: effects on enzymatic
RT   activities and virus replication.";
RL   Virus Res. 184:103-110(2014).
RN   [4]
RP   FUNCTION (PAPAIN-LIKE CYSTEINE PROTEASE), AND MUTAGENESIS OF HIS-443;
RP   CYS-472; CYS-481 AND CYS-483.
RX   PubMed=24795447; DOI=10.1099/vir.0.066142-0;
RA   Paliwal D., Panda S.K., Kapur N., Varma S.P., Durgapal H.;
RT   "Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that
RT   processes both non-structural (pORF1) and capsid (pORF2) protein.";
RL   J. Gen. Virol. 95:1689-1700(2014).
RN   [5]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE), AND MUTAGENESIS OF
RP   1551-ASN--ASN-1552.
RX   PubMed=27324050; DOI=10.1099/jgv.0.000528;
RA   Mahilkar S., Paingankar M.S., Lole K.S.;
RT   "Hepatitis E virus RNA-dependent RNA polymerase: RNA template
RT   specificities, recruitment and synthesis.";
RL   J. Gen. Virol. 97:2231-2242(2016).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29112323; DOI=10.1111/cmi.12804;
RA   Farhat R., Ankavay M., Lebsir N., Gouttenoire J., Jackson C.L.,
RA   Wychowski C., Moradpour D., Dubuisson J., Rouille Y., Cocquerel L.;
RT   "Identification of GBF1 as a cellular factor required for hepatitis E virus
RT   RNA replication.";
RL   Cell. Microbiol. 20:0-0(2018).
CC   -!- FUNCTION: Methyltransferase: Displays a capping enzyme activity. This
CC       function is necessary since all viral RNAs are synthesized in the
CC       cytoplasm, and host capping enzymes are restricted to the nucleus. The
CC       enzymatic reaction involves a covalent link between 7-methyl-GMP and
CC       the methyltransferase, whereas eukaryotic capping enzymes form a
CC       covalent complex only with GMP. Methyltransferase catalyzes transfer of
CC       a methyl group from S-adenosylmethionine to GTP and GDP to yield
CC       m(7)GTP or m(7)GDP. This enzyme also displays guanylyltransferase
CC       activity to form a covalent complex, methyltransferase-m(7)GMP, from
CC       which 7-methyl-GMP is transferred to the mRNA to create the cap
CC       structure.
CC   -!- FUNCTION: Papain-like cysteine protease: May participate in the
CC       processing of polyprotein pORF1 together with cellular proteases and
CC       the cleavage of capsid protein ORF2. {ECO:0000269|PubMed:24795447}.
CC   -!- FUNCTION: NTPase/helicase: Multi-functional protein that exhibits
CC       NTPase and RNA unwinding activities. Hydrolyzes all NTPs efficiently
CC       and unwinds RNA duplexes containing 5' overhangs. Possesses a sequence
CC       independent RNA-5'-triphosphatase (RTPase) activity suggestive of its
CC       role in forming viral cap structure (PubMed:20592074). Participates
CC       also in viral genome replication, RNA translocation and genome
CC       packaging/unpackaging (By similarity) (PubMed:24630891).
CC       {ECO:0000250|UniProtKB:P29324, ECO:0000269|PubMed:20592074,
CC       ECO:0000269|PubMed:24630891}.
CC   -!- FUNCTION: RNA-directed RNA polymerase: Plays an essential role in the
CC       virus replication. Binds to the 3'-end of the genomic RNA to initiate
CC       viral replication. {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate +
CC         RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:11128, Rhea:RHEA-
CC         COMP:11129, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:83400;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000269|PubMed:29112323}.
CC   -!- PTM: It is not yet clear whether the ORF1-encoded polyprotein contains
CC       multiple biochemical activities, or undergoes cis or trans- processing
CC       to release biochemically distinct peptides. No processing has been
CC       observed in mammalian expression systems. However, the baculovirus
CC       expressed polyprotein is processed into smaller protein, probably by a
CC       cysteine protease (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the hepevirus non-structural polyprotein family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96139.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94177; AAA96139.1; ALT_FRAME; Genomic_RNA.
DR   EMBL; L08816; AAA03182.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03183.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03184.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03185.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03186.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03187.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03188.1; -; Genomic_RNA.
DR   EMBL; L08816; AAA03189.1; -; Genomic_RNA.
DR   RefSeq; NP_056779.1; NC_001434.1.
DR   SMR; Q81862; -.
DR   PRIDE; Q81862; -.
DR   GeneID; 1494415; -.
DR   KEGG; vg:1494415; -.
DR   Proteomes; UP000006705; Genome.
DR   Proteomes; UP000102625; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008174; F:mRNA methyltransferase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003968; F:RNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006396; P:RNA processing; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0019082; P:viral protein processing; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   CDD; cd21557; Macro_X_Nsp3-like; 1.
DR   Gene3D; 3.40.220.10; -; 1.
DR   InterPro; IPR027351; (+)RNA_virus_helicase_core_dom.
DR   InterPro; IPR002588; Alphavirus-like_MT_dom.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR008748; Hepatitis-E_Cys-pept.
DR   InterPro; IPR022202; Hepatitis-E_hinge.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR044371; Macro_X_NSP3-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR001788; Tymovirus_RNA-dep_RNA_pol.
DR   Pfam; PF12526; DUF3729; 1.
DR   Pfam; PF05417; Peptidase_C41; 1.
DR   Pfam; PF00978; RdRP_2; 1.
DR   Pfam; PF01443; Viral_helicase1; 1.
DR   Pfam; PF01660; Vmethyltransf; 1.
DR   SMART; SM00506; A1pp; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF52949; SSF52949; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   PROSITE; PS51743; ALPHAVIRUS_MT; 1.
DR   PROSITE; PS51154; MACRO; 1.
DR   PROSITE; PS51657; PSRV_HELICASE; 1.
DR   PROSITE; PS50507; RDRP_SSRNA_POS; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Helicase; Host cytoplasm; Hydrolase; Methyltransferase;
KW   Nucleotide-binding; Nucleotidyltransferase; Protease; Reference proteome;
KW   RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase;
KW   Viral RNA replication.
FT   CHAIN           1..1693
FT                   /note="Non-structural polyprotein pORF1"
FT                   /id="PRO_0000402397"
FT   DOMAIN          56..240
FT                   /note="Alphavirus-like MT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01079"
FT   DOMAIN          775..921
FT                   /note="Macro"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00490"
FT   DOMAIN          934..1082
FT                   /note="(+)RNA virus helicase ATP-binding"
FT   DOMAIN          1083..1216
FT                   /note="(+)RNA virus helicase C-terminal"
FT   DOMAIN          1454..1565
FT                   /note="RdRp catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00539"
FT   NP_BIND         975..982
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          60..240
FT                   /note="Methyltransferase"
FT                   /evidence="ECO:0000250"
FT   REGION          239..439
FT                   /note="Y-domain"
FT                   /evidence="ECO:0000250"
FT   REGION          440..610
FT                   /note="Putative papain-like cysteine protease"
FT                   /evidence="ECO:0000250"
FT   REGION          712..778
FT                   /note="Hinge"
FT                   /evidence="ECO:0000250"
FT   REGION          785..942
FT                   /note="X-domain"
FT                   /evidence="ECO:0000250"
FT   REGION          960..1204
FT                   /note="NTPase/helicase"
FT                   /evidence="ECO:0000250"
FT   REGION          1207..1693
FT                   /note="RNA-directed RNA polymerase"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        714..761
FT                   /note="Pro-rich"
FT   COMPBIAS        990..995
FT                   /note="Poly-Val"
FT   COMPBIAS        1038..1041
FT                   /note="Poly-Leu"
FT   MUTAGEN         443
FT                   /note="H->A: Complete loss of capsid protein ORF2
FT                   cleavage."
FT                   /evidence="ECO:0000269|PubMed:24795447"
FT   MUTAGEN         472
FT                   /note="C->A: Complete loss of capsid protein ORF2
FT                   cleavage."
FT                   /evidence="ECO:0000269|PubMed:24795447"
FT   MUTAGEN         481
FT                   /note="C->A: Complete loss of capsid protein ORF2
FT                   cleavage."
FT                   /evidence="ECO:0000269|PubMed:24795447"
FT   MUTAGEN         483
FT                   /note="C->A: Complete loss of capsid protein ORF2
FT                   cleavage."
FT                   /evidence="ECO:0000269|PubMed:24795447"
FT   MUTAGEN         1110
FT                   /note="L->F: About 20% loss of viral replication,."
FT                   /evidence="ECO:0000269|PubMed:24630891"
FT   MUTAGEN         1120
FT                   /note="V->I: About 70% loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:24630891"
FT   MUTAGEN         1551..1552
FT                   /note="DD->AA: More than 95% loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:27324050"
SQ   SEQUENCE   1693 AA;  185054 MW;  D3363602435B8FF5 CRC64;
     MEAHQFIKAP GITTAIEQAA LAAANSALAN AVVVRPFLSH QQIEILINLM QPRQLVFRPE
     VFWNHPIQRV IHNELELYCR ARSGRCLEIG AHPRSINDNP NVVHRCFLRP AGRDVQRWYT
     APTRGPAANC RRSALRGLPA ADRTYCFDGF SGCNFPAETG VALYSLHDMS PSDVAEAMFR
     HGMTRLYAAL HLPPEVLLPP GTYRTASYLL IHDGRRVVVT YEGDTSAGYN HDVSNLRSWI
     RTTKVTGDHP LVIERVRAIG CHFVLLLTAA PEPSPTPYVP YPRSTEVYVR SIFGPGGTPS
     LFPTSCSTKS TFHAVPAHIW DRLMLFGATL DDQAFCCSRL MTYLRGISYK VTVGTLVANE
     GWNASEVALT AVITAAYLTI CHQRYLRTQA ISKGMRRLER EHAQKFITRL YSWLFEKSGR
     DYIPGRQLEF YAQCRRWLSA GFHLDPRVLV FDESAPCHCR TAIRKAVSKF CCFMKWLGQE
     CTCFLQPAEG AVGDQGHDNE AYEGSDVDPA ESAISDISGS YVVPGTALQP LYQALDLPAE
     IVARAGRLTA TVKVSQVDGR IDCETLLGNK TFRTSFVDGA VLETNGPERH NLSFDASQST
     MAAGPFSLTY AASAAGLEVR YVAAGLDHRA VFAPGVSPRS APGEVTAFCS ALYRFNREAQ
     RLSLTGNFWF HPEGLLGPFA PFSPGHVWES ANPFCGESTL YTRTWSEVDA VSSPAQPDLG
     FISEPSIPSR AATLTPAAPL PPPAPDPSPT PSAPARGEPA PGATARAPAI THQAARHRRL
     LFTYPDGSKV FAGSLFESTC TWLVNASNVD HRPGGGLCHA FYQRYPASFD AASFVMRDGA
     AAYTLTPRPI IHAVAPDYRL EHNPKMLEAA YRETCSRLGT AAYPLLGTGI YQVPIGPSFD
     AWERNHRPGD ELYLPELAAR WFEANRPTCP TLTITEDVAR TANLAIELDS ATDVGRACAG
     CRVTPGVVQY QFTAGVPGSG KSRSITQADV DVVVVPTREL RNAWRRRGFA AFTPHTAARV
     TQGRRVVIDE APSLPPHLLL LHMQRAATVH LLGDPNQIPA IDFEHAGLVP AIRPDLAPTS
     WWHVTHRCPA DVCELIRGAY PMIQTTSRVL RSLFWGEPAV GQKLVFTQAA KAANPGSVTV
     HEAQGATYTE TTIIATADAR GLIQSSRAHA IVALTRHTEK CVIIDAPGLL REVGISDAIV
     NNFFLAGGEI GHQRPSVIPR GNPDANVDTL AAFPPSCQIS AFHQLAEELG HRPAPVAAVL
     PPCPELEQGL LYLPQELTTC DSVVTFELTD IVHCRMAAPS QRKAVLSTLV GHYGRRTKLY
     NASHSDVRDS LARFIPAIGH VQVTTCELYE LVEAMVEKGQ DGSAVLELDL CNRDVSRITF
     FQKDCNKFTT GETIAHGKVG QGISAWSKTF CALFGPWFRA IEKAILALLP QGVFYGDAFD
     DTVFSAAVAA ARASMVFEND FSEFDSTQNN FSLGLECAIM VECGMPQWLI RLYHLIRSAW
     ILQAPKESLR GFWKKHSGEP GTLLWNTVWN MAVITHCYDF RDLQVAAFKG DDSIVLCSEY
     RQSPGAAVLI AGCGLKLKVD FRPIGLYAGV VVAPGLGALP DVVRFAGRLT EKNWGPGPER
     AKQLRLAVSD FLRKLTNVAQ MCVDVVSRVY GVSPGLVHNL IGMLQAVADG KAHFTESVKP
     VLDLTNSILC RVE
//
